Bright Minds Biosciences Inc.

C$26.00As of Sun 8 Nov 2026, 12:00 UTC
CSE:DRUGHealthcare
Country Canada
PE (Fwd) •••
TSR 6Y CAGR (6.43%)
Div yield —
ROE (13.63%)
Biotechnology
Beta (5Y) 0.20
PE TTM —
TSR TTM (66.26%)
Mkt cap C$256.5M
ROIC (13.61%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$27
3.69%
(89.53%)
Hold 1|5|5|9|12
1Q26
2Q26
3Q26
4Q26
Earnings per share$
0.39
0.41
0.39
0.42
18.64%
21.50%
7.64%
13.83%
Revenue$M
29.39
29.20
30.35
29.60
9.07%
11.35%
12.40%
5.04%
Peers (US$181.5M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.698
0.611
0.533
EBIT/Intx
2.265
0.052
0.047
Own earn%
39.73
(251.83)
(248.77)
Sh yield%
45.19
37.68
36.97
Owners
Insiders/Inst%
7.31
67.87
Short interest%
1.76
SBC / revenue%
3.47
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
6–12
$1 testx
—
Incr. ROIC%
1